Stock Market Analysis Video 5/20/2011

The stock charts used in this presentation are provided by WONDA ® Copyright © 2016 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

Brought to you by Cabot China & Emerging Markets Report

Editor Paul Goodwin says the U.S. markets have had an OK week, but things are a little bit rocky. Despite the market’s volatility, we still believe the long-term trend is up. Stocks discussed: MetroPCS Communications (PCS), Fossil (FOSL), Baidu (BIDU), Crocs (CROX).


Paul Goodwin Paul Goodwin
Emerging Markets Specialist, Analyst and Editor of Cabot China & Emerging Markets Report

A researcher and writer for over 30 years, Paul Goodwin has been a member of the Cabot investment team and editor of Cabot China & Emerging Markets Report since 2005. Under Paul’s stewardship, Hulbert Financial Digest rated Cabot China & Emerging Markets Report  the number-one-rated newsletter of 2006 with a 78.6% gain for the year, the number-one-rated newsletter of 2007 with a  74.1% return, and is currently the top-performing investment adivsory for five years with a 20.5% annualized return as of 12/31/10. Cabot China & Emerging Markets Report was also named 2007 Investment Letter of the Year by Peter Brimelow of MarketWatch.


And now a word from : Timothy Lutts, Cabot President and Chief Investment Strategist

"Cabot's China & Emerging Markets Report has racked up one of the most remarkable records ever recorded by the Hulbert Financial Digest. I named it Letter of the Year in 2007." — Peter Brimelow, MarketWatch, October 5, 2009

Dear Fellow Investor,

We're popping champagne corks after learning that Cabot China & Emerging Markets Report has once again been named one of the top-performing investment newsletter of the past five years, with a compound annual gain of 20.5% as of December 31, 2010.

Cabot China & Emerging Markets Report is rewarding its subscribers with a 154% total return over the past five years (an average annualized gain of 20.5% every year), compared to the compound annual return of 2.9% for the Wilshire 5000 over the same period.

I'm very proud of our achievement—for the whole Cabot team—but I'm kind of sad that so many investors are still stuck in underperforming broad-based U.S. investments ...

... while emerging markets stocks continue to make fortunes for investors with the courage and intelligence to venture out there.

So I'm going to do two things here.

First, I'm going to explain how Cabot China & Emerging Markets Report racked up this first place performance.

And second, I'm going to tell you how you can join our subscribers and profit from the fastest-growing major economies in the world.

The story begins back in 2004, when I noticed that an increasing number of Chinese stocks were performing well.

Upon investigation, I found the main reason was simple.

The Chinese economy was booming ... and there was a shortage of supply of Chinese stocks to invest in.

Putting two and two together, I figured it was a trend with the potential to last a long while, so I began publishing a newsletter called Cabot China & Emerging Markets Report.

And I instructed the editor, Paul Goodwin, to adhere to the time-tested Cabot growth investing system that has now served us for 40 years.

What this means, simply, is this:

He pays attention to charts, favoring stocks with strong momentum.

He pays attention to fundamentals, favoring young companies with good current growth and the promise of much more ahead. In China, which is growing so fast, great growth opportunities are pretty much everywhere.

And he pays attention to market timing ... which means his subscribers preserved profits last year by sitting in cash while most investors were watching their portfolios melt away.

The results have been gratifying, to say the least.

Moreover, the outperformance continues—in fact, while many U.S. stocks have been doing well in the bull move since March, Chinese stocks are still the undisputed leaders of the advance! Many more exciting young Chinese firms are being listed here on U.S. stock exchanges each month, and institutional investors have been piling in, eager to invest money in the biggest growth area in the world.

And if your goal is profits, I sincerely think you should consider joining them!

So, if you're ready to apply the lessons of a time-tested investment strategy ...

If you're ready to invest in the leading stocks of China ...

And if you're ready to take advice from the leading expert in the field, I invite you to join Paul's happy subscribers by taking a trial subscription to Cabot China & Emerging Markets Report.

Give it a try today. With my money-back guarantee, you've got nothing to lose and everything to gain!

Order Now  Learn More

Best wishes with all of your investments,

Timothy Lutts

Timothy Lutts

P.S.  A lot of people are still wondering whether this bull market is for real. I firmly believe it is, for the many reasons I've spelled out here in recent weeks, and I urge you not to delay investing any longer. Join Paul Goodwin's very satisfied Cabot China & Emerging Markets Report subscribers today.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >